戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ess a rounder inlet, which is beneficial for obstetrics.
2 de a summary of recent guidance on sepsis in obstetrics.
3 make it potentially very suitable for use in obstetrics.
4 ibuted to increasing the usefulness of US in obstetrics.
5 adult patients and relatives who visited the Obstetrics and Gynaecology and General Surgery Clinics o
6 scrub nurses were randomly selected from the Obstetrics and Gynaecology Department of a teaching hosp
7 of females, particularly those in outpatient obstetrics and gynecology (OB/GYN) settings.
8 ly transmitted disease, family planning, and obstetrics and gynecology clinics.
9 e recommendations of the American College of Obstetrics and Gynecology for women treated with tamoxif
10 or survival benefit, the American College of Obstetrics and Gynecology has recommendations for referr
11                                              Obstetrics and gynecology may present a different patter
12 03 patients with International Federation of Obstetrics and Gynecology stage III (n = 172) or IV (n =
13                                              Obstetrics and gynecology training programs can be ranke
14 tments were negative (anesthesiology, -1.1%; obstetrics and gynecology, -0.5%; radiology, -0.4%; and
15  GME in specialties such as general surgery, obstetrics and gynecology, and emergency medicine has in
16 specialties of psychiatry, child psychiatry, obstetrics and gynecology, and family and general practi
17 osurgery, radiology, cardiovascular surgery, obstetrics and gynecology, and general surgery.
18 armacy, telephone calls to the department of obstetrics and gynecology, and prenatal visits with phys
19 (ophthalmology, otalaryngology, dermatology, obstetrics and gynecology, and surgery).
20 , endocrinology, nephrology, psychiatry, and obstetrics and gynecology, but also from recognized expe
21 control group, born at the 1st Department of Obstetrics and Gynecology, Medical University of Warsaw,
22 geons across multiple specialties, including obstetrics and gynecology, otolaryngology, and orthopedi
23 ialties (internal medicine, family practice, obstetrics and gynecology, surgery, pediatrics, and psyc
24 y PR peer review databases were searched for obstetrics and gynecology-related keywords.
25                          Despite advances in obstetrics and neonatology, the rate of premature delive
26 logic outcomes of women participating in the Obstetrics and Periodontal Therapy (OPT) Study.
27                     A recent clinical trial (Obstetrics and Periodontal Therapy [OPT] Study) demonstr
28 es in the management of sickle cell disease, obstetrics, and neonatal medicine, pregnancies complicat
29 of pregnancy complications: a mouse model of obstetrics antiphospholipid syndrome (APS) and a mouse m
30 commercial equipment, that its usefulness in obstetrics began to be realized fully by radiologists an
31 or at a tertian-care center with a high-risk obstetrics/cardiology clinic and 66 individually selecte
32 uch methods are of great significance to the obstetrics community because of their potential use as c
33                                              Obstetrics complications and excessive bleeding during d
34 r International Federation of Gynecology and Obstetrics (FIGO) grade (P < .0001).
35 h International Federation of Gynecology and Obstetrics (FIGO) high-risk stage I-IV epithelial ovaria
36 , International Federation of Gynecology and Obstetrics (FIGO) stage distribution, and methodologic q
37 e International Federation of Gynecology and Obstetrics (FIGO) stage I (including borderline), two st
38 h International Federation of Gynecology and Obstetrics (FIGO) stage IB to IV cervical cancer between
39 n International Federation of Gynecology and Obstetrics (FIGO) stage IC-IV epithelial ovarian cancer
40 e International Federation of Gynecology and Obstetrics (FIGO) stage of ECs, respectively.
41 g International Federation of Gynecology and Obstetrics (FIGO) stage.
42 , International Federation of Gynecology and Obstetrics (FIGO) stages IIB through IVA, when lesions a
43 d International Federation of Gynecology and Obstetrics (FIGO) staging system for uterine cancer.
44  (International Federation of Gynecology and Obstetrics [FIGO] stage I-IIa, grade 3 or clear cell his
45  (International Federation of Gynecology and Obstetrics [FIGO] stage III), for which the standard of
46 siologists in a variety of circumstances: in obstetrics for labor and emergencies, in trauma for emer
47  Fowler position, widely used in surgery and obstetrics for patient placement, marks a fraction of 19
48 , International Federation of Gynecology and Obstetrics grade, or adjuvant treatment.
49 tern Med), the Annals of Surgery (Ann Surg), Obstetrics & Gynecology (Obstet Gynecol), and the Journa
50             The authors evaluated whether an obstetrics-gynecology clinic-based collaborative depress
51 seeking care in the general medical care and obstetrics-gynecology clinics of an urban public hospita
52 om 787 female patients attending one of four obstetrics-gynecology clinics.
53 November 2010 among postgraduate trainees in obstetrics-gynecology in 7 LMICs (Argentina, Brazil, Dem
54     Collaborative depression care adapted to obstetrics-gynecology settings had a greater impact on d
55 teen studies looked at general surgery, 6 at obstetrics-gynecology, 2 at urology, and 1 at otolaryngo
56 ar to be inclusive, because family medicine, obstetrics-gynecology, orthopedic surgery, and neurology
57 se exposures, 82% occurred on four services: obstetrics-gynecology, surgery, medicine, and emergency
58 taking internal medicine first compared with obstetrics/gynecology (mean difference, 0.65; 95% CI, 0.
59                             Family planning, obstetrics/gynecology (OB/GYN), or sexually transmitted
60 h-year medical students completing an 8-week obstetrics/gynecology clinical rotation, attendance at c
61                                The number of obstetrics/gynecology male graduates decreased 31.3%, wh
62 ear medical students who completed an 8-week obstetrics/gynecology rotation were included.
63 ase in debt (vs no debt), graduates choosing obstetrics/gynecology were less likely to be board certi
64 sistent recommendations varied by specialty (obstetrics/gynecology, 16.4%; internal medicine, 27.5%;
65 ernal medicine, 25.33 [95% CI, 25.07-25.60], obstetrics/gynecology, 24.68 [95% CI, 24.32-25.05], pedi
66 ernal medicine, 73.86 [95% CI, 73.33-74.39], obstetrics/gynecology, 72.36 [95% CI, 71.64-73.04], pedi
67 l surgery, neurosurgery, orthopedic surgery, obstetrics/gynecology, emergency medicine, and radiology
68 ernal medicine, pediatrics, family practice, obstetrics/gynecology, general surgery, orthopedic surge
69 urgery, vascular surgery, pediatric surgery, obstetrics/gynecology, ophthalmology, and urology (n = 1
70                             Critical care in obstetrics has many similarities in pathophysiology to t
71     A substantial number of women treated in obstetrics have unrecognized and untreated psychiatric d
72 other-infant pairs were recruited at a large obstetrics hospital in Mexico City, Mexico, randomly ass
73  is not yet legalized in Japan, at least 153 obstetrics hospitals and 3320 clinics have closed.
74 aff and represented cardiovascular medicine, obstetrics, immunology, and pathology.
75 ssigned to US rotation, (b) the inclusion of obstetrics in US rotation, and (c) the opportunity for h
76               The need to evaluate high-risk obstetrics is increasingly recognized.
77           The management of severe sepsis in obstetrics is multidisciplinary.
78                               A challenge in obstetrics is to distinguish pathological symptoms from
79     Because Medicare DRGs are unsuitable for obstetrics, pediatrics, and neonatology, some payers pre
80 g, bone marrow transplantation, ethics, law, obstetrics, pediatrics, and the social sciences were inv
81  (International Federation of Gynecology and Obstetrics score >/= 7) gestational trophoblastic neopla
82 rienced hematologist/oncologist, a high-risk obstetrics specialist, a neonatologist, and experienced
83  (International Federation of Gynecology and Obstetrics stage 0 to IIIB).
84 y International Federation of Gynecology and Obstetrics stage I and low grade.
85 r International Federation of Gynecology and Obstetrics stage I or II carcinoma of the cervix were re
86 k International Federation of Gynecology and Obstetrics stage I or stage II to IV epithelial ovarian,
87 h International Federation of Gynecology and Obstetrics stage IB1 cervical carcinoma who underwent at
88 h International Federation of Gynecology and Obstetrics stage Ic to IV disease to six cycles of docet
89 h International Federation of Gynecology and Obstetrics stage IIB to IV ovarian, fallopian tube, or p
90 f International Federation of Gynecology and Obstetrics stage III or IV epithelial ovarian cancer, bi
91 h International Federation of Gynecology and Obstetrics stage III or IV tumors received chemotherapy,
92  (International Federation of Gynecology and Obstetrics stage III or IV) who underwent first-line pla
93 h International Federation of Gynecology and Obstetrics stage III to IV ovarian cancer in complete cl
94 h International Federation of Gynecology and Obstetrics stage IV EOC who underwent primary surgery fo
95 y International Federation of Gynecology and Obstetrics stage) 9 or fewer months previously.
96 , International Federation of Gynecology and Obstetrics stage, tumor grade, pelvic node status, and t
97 d International Federation of Gynecology and Obstetrics stage.
98 r International Federation of Gynecology and Obstetrics stage.
99 l International Federation of Gynecology and Obstetrics stages IB2 (n = 79), IIA (n = 10), IIB (n = 1
100 d International Federation of Gynecology and Obstetrics stages II to IV or relapsed stage I epithelia
101  International Federation of Gynaecology and Obstetrics stages IIB, III, or IVA.
102  (International Federation of Gynecology and Obstetrics stages IIIC and IV) ovarian cancer.
103 d International Federation of Gynecology and Obstetrics staging of gynecologic malignancies are also
104 e International Federation of Gynecology and Obstetrics staging system's stage, residual disease, his
105 h opens new horizons for drug development in obstetrics that could greatly impact preterm birth, whic
106           Here we show for the first time in obstetrics the use of a targeted nanoparticle directed t
107 used for large numbers of patients attending obstetrics units.
108 e (median) episiotomy has no place in modern obstetrics; when episiotomy must be performed for obstet

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top